Health Care & Life Sciences » Pharmaceuticals | Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC
Stock Exchange Other OTC
EPS
 $0.31
Market Cap
 $3.58 B
Shares Outstanding
 102.33 M
Public Float
 -
Dechra Pharmaceuticals PLC
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 102.33 M
Public Float
 -
Dechra Pharmaceuticals PLC
Stock Exchange London Stock Exchange
EPS
 GBP0.23
Market Cap
 GBP2.86 B
Shares Outstanding
 102.33 M
Public Float
 96.84 M

Profile

Address
Cheshire Business Park
Northwich Cheshire CW9 7UA
United Kingdom
Employees -
Website http://dechra.com
Updated 07/08/2019
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe.

Financials

View All
Created with Highcharts 5.0.14Dechra Pharmaceuticals PLCNet Income. Fiscal year is July-June. All values GBP Thousands.19 41619 41619 45919 45912 66812 66826 10526 10536 10036 10020142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Dechra Pharmaceuticals PLCSales/Revenue. Fiscal year is July-June. All values GBP Thousands.193 571193 571203 480203 480247 562247 562359 275359 275407 100407 100201420152016201720180100k200k300k400k500k

William Anthony Rice
Non-Executive Chairman
Ian Page
Chief Executive Officer & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.